Compile Data Set for Download or QSAR
Found 285 with Last Name = 'imaizumi' and Initial = 't'
TargetTrypsinogen 16(Mus musculus (Mouse))
Astellas Pharma Inc.

US Patent
LigandPNGBDBM193349(US9199927, 108 | US9199927, 60)copy SMILEScopy InChI
Affinity DataIC50: 0.140nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2P26WXNUS Patent
TargetTrypsinogen 16(Mus musculus (Mouse))
Astellas Pharma Inc.

US Patent
LigandPNGBDBM193350(US9199927, 61)copy SMILEScopy InChI
Affinity DataIC50: 0.140nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2P26WXNUS Patent
TargetTrypsinogen 16(Mus musculus (Mouse))
Astellas Pharma Inc.

US Patent
LigandPNGBDBM193317(US9199927, 28)copy SMILEScopy InChI
Affinity DataIC50: 0.170nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2P26WXNUS Patent
TargetTrypsinogen 16(Mus musculus (Mouse))
Astellas Pharma Inc.

US Patent
LigandPNGBDBM193313(US9199927, 24)copy SMILEScopy InChI
Affinity DataIC50: 0.170nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2P26WXNUS Patent
TargetTrypsinogen 16(Mus musculus (Mouse))
Astellas Pharma Inc.

US Patent
LigandPNGBDBM193351(US9199927, 62)copy SMILEScopy InChI
Affinity DataIC50: 0.170nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2P26WXNUS Patent
TargetSerine protease 1(Homo sapiens (Human))
Astellas Pharma Inc.

US Patent
LigandPNGBDBM193290(US9199927, 1)copy SMILEScopy InChI
Affinity DataIC50: 0.170nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2P26WXNUS Patent
TargetTrypsinogen 16(Mus musculus (Mouse))
Astellas Pharma Inc.

US Patent
LigandPNGBDBM193310(US9199927, 21)copy SMILEScopy InChI
Affinity DataIC50: 0.170nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2P26WXNUS Patent
TargetTrypsinogen 16(Mus musculus (Mouse))
Astellas Pharma Inc.

US Patent
LigandPNGBDBM193315(US9199927, 26)copy SMILEScopy InChI
Affinity DataIC50: 0.180nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2P26WXNUS Patent
TargetSerine protease 1(Homo sapiens (Human))
Astellas Pharma Inc.

US Patent
LigandPNGBDBM193360(US9199927, 71)copy SMILEScopy InChI
Affinity DataIC50: 0.180nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2P26WXNUS Patent
TargetTrypsinogen 16(Mus musculus (Mouse))
Astellas Pharma Inc.

US Patent
LigandPNGBDBM193304(US9199927, 15)copy SMILEScopy InChI
Affinity DataIC50: 0.190nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2P26WXNUS Patent
TargetSerine protease 1(Homo sapiens (Human))
Astellas Pharma Inc.

US Patent
LigandPNGBDBM193349(US9199927, 108 | US9199927, 60)copy SMILEScopy InChI
Affinity DataIC50: 0.190nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2P26WXNUS Patent
TargetTrypsinogen 16(Mus musculus (Mouse))
Astellas Pharma Inc.

US Patent
LigandPNGBDBM193290(US9199927, 1)copy SMILEScopy InChI
Affinity DataIC50: 0.190nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2P26WXNUS Patent
TargetTrypsinogen 16(Mus musculus (Mouse))
Astellas Pharma Inc.

US Patent
LigandPNGBDBM193316(US9199927, 27)copy SMILEScopy InChI
Affinity DataIC50: 0.190nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2P26WXNUS Patent
TargetTrypsinogen 16(Mus musculus (Mouse))
Astellas Pharma Inc.

US Patent
LigandPNGBDBM193319(US9199927, 30)copy SMILEScopy InChI
Affinity DataIC50: 0.190nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2P26WXNUS Patent
TargetTrypsinogen 16(Mus musculus (Mouse))
Astellas Pharma Inc.

US Patent
LigandPNGBDBM193311(US9199927, 22)copy SMILEScopy InChI
Affinity DataIC50: 0.200nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
Ligand InfoKEGGPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2P26WXNUS Patent
TargetSerine protease 1(Homo sapiens (Human))
Astellas Pharma Inc.

US Patent
LigandPNGBDBM193304(US9199927, 15)copy SMILEScopy InChI
Affinity DataIC50: 0.200nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2P26WXNUS Patent
TargetTrypsinogen 16(Mus musculus (Mouse))
Astellas Pharma Inc.

US Patent
LigandPNGBDBM193318(US9199927, 29)copy SMILEScopy InChI
Affinity DataIC50: 0.210nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2P26WXNUS Patent
TargetTrypsinogen 16(Mus musculus (Mouse))
Astellas Pharma Inc.

US Patent
LigandPNGBDBM193349(US9199927, 108 | US9199927, 60)copy SMILEScopy InChI
Affinity DataIC50: 0.210nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2P26WXNUS Patent
TargetSerine protease 1(Homo sapiens (Human))
Astellas Pharma Inc.

US Patent
LigandPNGBDBM193369(US9199927, 80)copy SMILEScopy InChI
Affinity DataIC50: 0.210nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2P26WXNUS Patent
TargetSerine protease 1(Homo sapiens (Human))
Astellas Pharma Inc.

US Patent
LigandPNGBDBM193349(US9199927, 108 | US9199927, 60)copy SMILEScopy InChI
Affinity DataIC50: 0.210nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2P26WXNUS Patent
TargetSerine protease 1(Homo sapiens (Human))
Astellas Pharma Inc.

US Patent
LigandPNGBDBM193313(US9199927, 24)copy SMILEScopy InChI
Affinity DataIC50: 0.210nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2P26WXNUS Patent
TargetTrypsinogen 16(Mus musculus (Mouse))
Astellas Pharma Inc.

US Patent
LigandPNGBDBM193303(US9199927, 14)copy SMILEScopy InChI
Affinity DataIC50: 0.220nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2P26WXNUS Patent
TargetSerine protease 1(Homo sapiens (Human))
Astellas Pharma Inc.

US Patent
LigandPNGBDBM193414(US9199927, 96)copy SMILEScopy InChI
Affinity DataIC50: 0.220nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2P26WXNUS Patent
TargetTrypsinogen 16(Mus musculus (Mouse))
Astellas Pharma Inc.

US Patent
LigandPNGBDBM193360(US9199927, 71)copy SMILEScopy InChI
Affinity DataIC50: 0.230nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2P26WXNUS Patent
TargetSerine protease 1(Homo sapiens (Human))
Astellas Pharma Inc.

US Patent
LigandPNGBDBM193350(US9199927, 61)copy SMILEScopy InChI
Affinity DataIC50: 0.230nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2P26WXNUS Patent
TargetSerine protease 1(Homo sapiens (Human))
Astellas Pharma Inc.

US Patent
LigandPNGBDBM193305(US9199927, 16)copy SMILEScopy InChI
Affinity DataIC50: 0.230nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2P26WXNUS Patent
TargetSerine protease 1(Homo sapiens (Human))
Astellas Pharma Inc.

US Patent
LigandPNGBDBM193303(US9199927, 14)copy SMILEScopy InChI
Affinity DataIC50: 0.230nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2P26WXNUS Patent
TargetTrypsinogen 16(Mus musculus (Mouse))
Astellas Pharma Inc.

US Patent
LigandPNGBDBM193323(US9199927, 34)copy SMILEScopy InChI
Affinity DataIC50: 0.240nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2P26WXNUS Patent
TargetSerine protease 1(Homo sapiens (Human))
Astellas Pharma Inc.

US Patent
LigandPNGBDBM193395(US9199927, 113)copy SMILEScopy InChI
Affinity DataIC50: 0.240nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2P26WXNUS Patent
TargetSerine protease 1(Homo sapiens (Human))
Astellas Pharma Inc.

US Patent
LigandPNGBDBM193317(US9199927, 28)copy SMILEScopy InChI
Affinity DataIC50: 0.240nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2P26WXNUS Patent
TargetTrypsinogen 16(Mus musculus (Mouse))
Astellas Pharma Inc.

US Patent
LigandPNGBDBM193314(US9199927, 25)copy SMILEScopy InChI
Affinity DataIC50: 0.25nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2P26WXNUS Patent
TargetSerine protease 1(Homo sapiens (Human))
Astellas Pharma Inc.

US Patent
LigandPNGBDBM193310(US9199927, 21)copy SMILEScopy InChI
Affinity DataIC50: 0.260nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2P26WXNUS Patent
TargetTrypsinogen 16(Mus musculus (Mouse))
Astellas Pharma Inc.

US Patent
LigandPNGBDBM193305(US9199927, 16)copy SMILEScopy InChI
Affinity DataIC50: 0.260nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2P26WXNUS Patent
TargetSerine protease 1(Homo sapiens (Human))
Astellas Pharma Inc.

US Patent
LigandPNGBDBM193319(US9199927, 30)copy SMILEScopy InChI
Affinity DataIC50: 0.260nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2P26WXNUS Patent
TargetSerine protease 1(Homo sapiens (Human))
Astellas Pharma Inc.

US Patent
LigandPNGBDBM193316(US9199927, 27)copy SMILEScopy InChI
Affinity DataIC50: 0.260nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2P26WXNUS Patent
TargetTrypsinogen 16(Mus musculus (Mouse))
Astellas Pharma Inc.

US Patent
LigandPNGBDBM193306(US9199927, 17)copy SMILEScopy InChI
Affinity DataIC50: 0.270nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2P26WXNUS Patent
TargetSerine protease 1(Homo sapiens (Human))
Astellas Pharma Inc.

US Patent
LigandPNGBDBM193348(US9199927, 59)copy SMILEScopy InChI
Affinity DataIC50: 0.270nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2P26WXNUS Patent
TargetTrypsinogen 16(Mus musculus (Mouse))
Astellas Pharma Inc.

US Patent
LigandPNGBDBM193312(US9199927, 23)copy SMILEScopy InChI
Affinity DataIC50: 0.280nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2P26WXNUS Patent
TargetTrypsinogen 16(Mus musculus (Mouse))
Astellas Pharma Inc.

US Patent
LigandPNGBDBM193395(US9199927, 113)copy SMILEScopy InChI
Affinity DataIC50: 0.280nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2P26WXNUS Patent
TargetTrypsinogen 16(Mus musculus (Mouse))
Astellas Pharma Inc.

US Patent
LigandPNGBDBM193324(US9199927, 35)copy SMILEScopy InChI
Affinity DataIC50: 0.280nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2P26WXNUS Patent
TargetSerine protease 1(Homo sapiens (Human))
Astellas Pharma Inc.

US Patent
LigandPNGBDBM193311(US9199927, 22)copy SMILEScopy InChI
Affinity DataIC50: 0.290nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
Ligand InfoKEGGPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2P26WXNUS Patent
TargetSerine protease 1(Homo sapiens (Human))
Astellas Pharma Inc.

US Patent
LigandPNGBDBM193314(US9199927, 25)copy SMILEScopy InChI
Affinity DataIC50: 0.290nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2P26WXNUS Patent
TargetSerine protease 1(Homo sapiens (Human))
Astellas Pharma Inc.

US Patent
LigandPNGBDBM193415(US9199927, 102)copy SMILEScopy InChI
Affinity DataIC50: 0.290nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2P26WXNUS Patent
TargetSerine protease 1(Homo sapiens (Human))
Astellas Pharma Inc.

US Patent
LigandPNGBDBM193351(US9199927, 62)copy SMILEScopy InChI
Affinity DataIC50: 0.290nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2P26WXNUS Patent
TargetSerine protease 1(Homo sapiens (Human))
Astellas Pharma Inc.

US Patent
LigandPNGBDBM193315(US9199927, 26)copy SMILEScopy InChI
Affinity DataIC50: 0.290nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2P26WXNUS Patent
TargetTrypsinogen 16(Mus musculus (Mouse))
Astellas Pharma Inc.

US Patent
LigandPNGBDBM193369(US9199927, 80)copy SMILEScopy InChI
Affinity DataIC50: 0.300nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2P26WXNUS Patent
TargetSerine protease 1(Homo sapiens (Human))
Astellas Pharma Inc.

US Patent
LigandPNGBDBM193341(US9199927, 52)copy SMILEScopy InChI
Affinity DataIC50: 0.300nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2P26WXNUS Patent
TargetTrypsinogen 16(Mus musculus (Mouse))
Astellas Pharma Inc.

US Patent
LigandPNGBDBM193415(US9199927, 102)copy SMILEScopy InChI
Affinity DataIC50: 0.300nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2P26WXNUS Patent
TargetTrypsinogen 16(Mus musculus (Mouse))
Astellas Pharma Inc.

US Patent
LigandPNGBDBM193330(US9199927, 41)copy SMILEScopy InChI
Affinity DataIC50: 0.310nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2P26WXNUS Patent
TargetSerine protease 1(Homo sapiens (Human))
Astellas Pharma Inc.

US Patent
LigandPNGBDBM193320(US9199927, 31)copy SMILEScopy InChI
Affinity DataIC50: 0.310nMpH: 8.0 T: 2°CAssay Description:The compound was dissolved in dimethyl sulfoxide (DMSO), and diluted to an arbitrary concentration (A). A was 100-fold diluted with a buffer (0.1 M T...More data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2P26WXNUS Patent
Displayed 1 to 50 (of 285 total ) | Next | Last >>
Jump to: